Cellonis Biotechnologies Group is a China based biotechnology company focus primarily on the development and applying of novel stem cell technologies for providing the effective, patient-specific therapies to patients with degenerative central nervous system (CNS) disorders, cardiovascular diseases, liver diseases and cancers.
Based on the over 5 years experience of extensive research and treatment protocol development, we have built up an advance stem cell platform technology and more than 5 stem cell therapy programs have been used by partner hospitals for clinical research and treatment.
| 
More Information
More links
